- February 05, 2012
- 02:04 PM CET
- search
- T&C's
- Disclaimer
- PRIVACY POLICY
- Imprint
- RSS
- ©2012 EVOTEC
Evotec - Research never stops
- Loading...
Overview of Product development partnerships
Evotec's clinical programmes are almost exclusively developed in partnerships with pharmaceutical companies.
| Partner | Indication | Status | Next milestone | |
| Teva/Andromeda | Type 1 diabetes | DiaPep277, synthetic peptide modulator | Phase III | Phase II data 2012 |
| Roche | Alzheimer's Disease | MAO-B inhibitor | Phase II | Phase IIb start in 2012 |
| JingXin | Insomnia | EVT 201, GabaA | Phase II | Clinical start in China 2011 |
| Boehringer Ingelheim | Pain | not named | Phase I | Phase I |
| Pfizer | Pain | TRPV1 antagonist | Phase I /Preclinical | First Phase I stopped, back-up in preparation |
| Animal Health company (undisclosed) | Inflammatory diseases | EVT 401 | Phase I / II | Phase II start in 2012 |